Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Current Assets:
Cash and cash equivalents	$ 33,030	$ 41,419
Available-for-sale securities	7,909	3,933
Accounts receivable, net of allowances of $107 and $80 as of March 31, 2024 and September 30, 2023, respectively	12,319	10,850
Contract assets	10,650	7,796
Inventories	15,405	14,839
Income tax receivable	746	491
Prepaids and other	4,204	7,363
Total Current Assets	84,263	86,691
Property and equipment, net	25,718	26,026
Intangible assets, net	24,784	26,206
Goodwill	43,576	42,946
Other assets	4,464	3,864
Total Assets	182,805	185,733
Current Liabilities:
Accounts payable	3,186	2,993
Accrued liabilities:
Compensation	6,245	10,139
Accrued other	5,017	6,444
Deferred revenue	4,749	4,378
Total Current Liabilities	19,197	23,954
Long-term debt, net	29,480	29,405
Deferred revenue, less current portion		2,400
Deferred income taxes	1,857	2,004
Other long-term liabilities	8,321	8,060
Total Liabilities	58,855	65,823
Commitments and Contingencies (Note 11)
Stockholders’ Equity:
Series A Preferred stock - $.05 par value, 450 shares authorized; no shares issued and outstanding
Common stock - $.05 par value, 45,000 shares authorized; 14,260 and 14,155 shares issued and outstanding as of March 31, 2024 and September 30, 2023, respectively	713	708
Additional paid-in capital	40,271	36,706
Accumulated other comprehensive loss	(3,750)	(4,759)
Retained earnings	86,716	87,255
Total Stockholders’ Equity	123,950	119,910
Total Liabilities and Stockholders’ Equity	$ 182,805	$ 185,733